test

The NLA’s Masters in Lipidology course has been completely revised for 2024. The new course format is intended to provide advanced training to Lipid Specialists and other health care professionals in the treatment of complex lipid disorders. Through case discussions, practical application in practice and the various treatment opinions from the expert faculty, participants in the course will leave with confidence in their role as a consultative lipid specialist. Faculty and guest panelists will cover a number of complex disorders in each course offering. Topics and faculty may vary by course date and location. Participants in this course will learn how to recognize and diagnose complex lipid disorders. The course will also describe the various treatment options for each disorder, key clinical trial data for pharmacologic therapies, and how to develop treatment plans.

Masters in Lipidology is offered as a 2-day course prior to NLA meetings (Clinical Lipid Updates [CLU] and Scientific Sessions).

2024 Course Dates:

2025 Course Dates:

 

Course Curriculum:

Complex Cases and Consultative Lipidology

Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, advance practice registered nurses, nurse practitioners and registered dietitians with expertise in Lipidology looking for further advanced training.

Pricing*
Member cost: $750
Non-Member cost: $1,250
Trainee cost: $395

*Pricing subject to change

At the conclusion of this activity, participants should be able to:

  • Recognize lipid disorders including (insert Consultative Case Module topics selected) through case discussions.
  • Describe mechanism of action, pharmacokinetics, and efficacy of approved therapies to treat lipid disorders.
  • Evaluate data from key clinical trials of lipid-altering drug therapies.
  • Diagnose complex lipid disorders.
  • Compose a treatment plan for patients with complex lipid disorders.
  • Distinguish roles in a team-based approach to care.
  • Discuss strategies to improve the knowledge, skills or performance of the healthcare team.

CME/CE credit provided by the National Lipid Association 

 

 

In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.5 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Physician Assistants
NCCPA accepts AMA PRA Category I Credit™ from organizations accredited by ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 14.5 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL002.

Pharmacists

Universal Activity Number – JA0007192-0000-24-027-L01-P (Application)
This Activity has been approved for 14.5 contact hour(s) (1.45 CEUs) of the Accreditation Council for Pharmacy Education.

Nursing
The maximum number of hours awarded for this CE activity is 14.5 contact hours.
Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

 

 

CRITERIA FOR SUCCESS:
Statements of credit will be awarded based on the participant´s attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.lipid.org/cme. The deadline to claim credit is October 8, 2024. Questions related to this content should be sent to cme@lipid.org.

 

FOR PHARMACISTS: Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

FOR DIETITIANS: Upon completion of the activity evaluation form, dietitians may submit evaluations of the quality of activities/materials to CDR. Poor evaluations of activities/materials may trigger an audit of the activities / materials by CDR.

COMMERCIAL SUPPORT
Full notification of commercial support will be provided in the meeting application.

DISCLOSURE OF UNLABELED USE AND INVESTIGATIONAL PRODUCTS
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLOSURE DECLARATION
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. Planners, faculty, reviewers, and staff have disclosed any financial relationships with commercial interests as defined by the ACCME

DISCLAIMER
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. The NLA specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader’s misunderstanding of content.

PERMISSIONS
The National Lipid Association acknowledges that permissions have been obtained for use of all copyrighted materials, including graphs, tables, pictures, and charts printed in this activity syllabus. Permissions have also been obtained from identifiable patients in photographs and other images, consistent with the DHHS HIPAA regulations for individual privacy.

Jessica M. Peña, MD, MPH, FNLA

Course Co-Chair
Associate Professor of Clinical Medicine
Associate Professor of Medicine in Clinical Radiology
Director, HeartHealth, Dalio Institute of Cardiovascular Imaging
Weill Cornell Medicine and NewYork- Presbyterian Hospital
New York, NY

James A. Underberg, MD, MS, MNLA

Course Co-Chair
Lipidology & Cardiovascular Disease Prevention
Clinical Assistant Professor of Medicine
NYU Medical School & NYU Center for CV Prevention
Director, Bellevue Hospital Lipid Clinic
Past-President, National Lipid Association 
Past-President, American Board of Clinical Lipidology
President, Foundation of the National Lipid Association
New York, NY

Michael J. Blaha, MD, MPH

Professor of Cardiology and Epidemiology
Director of Clinical Research
Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease
Baltimore, MD

 

Alan S. Brown, MD, MNLA

Director, Lipid Clinic
Advocate Lutheran General Hospital
Clinical Associate Professor of Medicine
Rosalind Franklin School of Medicine and Science
Loyola University
Chicago, IL

 

P. Barton Duell, MD, FNLA

Professor of Medicine
Director, Sterol Analysis Laboratory
Director, LDL/Lipoprotein Apheresis Unit
Center for Preventive Cardiology
Knight Cardiovascular Institute
Division of Endocrinology, Diabetes & Clinical Nutrition
Oregon Health Sciences University
Portland, OR

 

Kevin C. Maki, PhD, CLS, MNLA

President and Chief Scientist
Midwest Biomedical Research
Addison, IL
Adjunct Professor
Dean’s Eminent Scholar
Indiana University School of Public Health
Bloomington, IN

 

Michael J. Wilkinson, MD, FNLA

Assistant Professor of Medicine
UC San Diego Health
San Diego, CA

Kathleen L. Wyne, MD, PhD, FNLA

Professor – Clinical
Division of Endocrinology, Diabetes and Metabolism
The Ohio State University
Columbus, OH

 

Thursday, September 5, 2024

Day 1

7:00 AM - 7:30 AM Registration and Breakfast
7:30 AM - 7:45 AM Course Overview Kathleen L. Wyne, MD, PhD, FNLA
7:45 AM - 9:45 AM Consultative Case: HDL and Cardiovascular Risk P. Barton Duell, MD, FNLA
9:45 AM - 10:00 AM Break
10:00 AM - 12:00 PM Consultative Case: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Kathleen L. Wyne, MD, PhD, FNLA
12:00 PM - 1:00 PM Lunch
1:00 PM - 3:00 PM Consultative Case: Familial Hypercholesterolemia Jessica M. Peña, MD, FNLA
3:00 PM - 3:15 PM Break
3:15 PM - 5:15 PM Consultative Case: Lipoprotein(a) Michael Wilkinson, MD

Friday, September 6, 2024

Day 2

7:00 AM - 7:30 AM Breakfast
7:30 AM - 7:45 AM Recap Cases Day 1 James A. Underberg, MD, MS, MNLA
7:45 AM - 9:45 AM Consultative Case: Precision Imaging for Personalized Therapy Michael Blaha, MD
9:45 AM - 10:00 AM Break
10:00 AM - 12:00 PM Consultative Case: Familial Chylomicronemia Syndrome (FCS Alan S. Brown, MD, MNLA
12:00 PM - 1:00 PM Lunch
1:00 PM - 2:00 PM New Therapies in Development Kevin C. Maki, PhD, CLS, MNLA
2:00 PM - 2:30 PM Panel Discussion and Post-Test James A. Underberg, MD, MS, MNLA